Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Recent changes appear to be updates to study record dates (e.g., 2025-10-28, 2025-10-09, 2025-10) and do not alter core content such as design, eligibility, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:14:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated the site version from v3.0.2 to v3.2.0; this is a metadata/versioning change with no other content changes.
    Difference
    0.0%
    Check dated 2025-10-01T03:55:49.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated version 3.0.2 metadata: new dates (2025-09-15, 2025-09-11, 2025-09), new location strings (México, Mexico, 03100 and 14080), and updated label (Last Update Posted (Estimated)); removed older dates and revision 3.0.1 and the Back to Top item.
    Difference
    0.5%
    Check dated 2025-09-16T19:47:01.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page update is limited to metadata/UI changes: the revision label was updated from v3.0.0 to v3.0.1 and a 'Back to Top' link was added; there are no changes to core content, pricing, stock availability, or scheduling.
    Difference
    0.1%
    Check dated 2025-09-09T15:19:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new drug information for Lazertinib and Amivantamab, as well as numerous location details across various countries. Additionally, the facility name has been included, while some previous location entries and drug information have been removed.
    Difference
    19%
    Check dated 2025-09-02T08:16:03.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates from July 2025 and adding new dates in August 2025.
    Difference
    0.3%
    Check dated 2025-08-26T06:28:49.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.